Insulindegrading enzyme: structure-function relationship and its possible roles in health and disease, Curr. Pharm. Des, vol.15, pp.3644-3655, 2009. ,
The insulysin (insulin degrading enzyme) enigma, Cell. Mol. Life Sci, vol.63, pp.2432-2434, 2006. ,
Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme, FEBS Lett, vol.345, pp.33-37, 1994. ,
Molecular basis for the recognition and cleavages of IGF-II, TGF-[alpha], and amylin by human insulin-degrading enzyme, J. Mol. Biol, vol.395, pp.430-443, 2010. ,
Endosomal proteolysis of glucagon at neutral pH generates the bioactive degradation product miniglucagon-(19-29), Endocrinology, vol.144, pp.5353-5364, 2003. ,
An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures, Diabetes, vol.52, pp.2315-2320, 2003. ,
Somatostatin: a novel substrate and a modulator of insulindegrading enzyme activity, J. Mol. Biol, vol.385, pp.1556-1567, 2009. ,
Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme, FEBS Lett, vol.427, pp.153-156, 1998. ,
Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism, Nature, vol.443, pp.870-874, 2006. ,
Amyloid b-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin, Cell. Mol. Life Sci, vol.65, pp.2574-2585, 2008. ,
Functional relevance of a novel SlyX motif in non-conventional secretion of insulin-degrading enzyme, J. Biol. Chem, vol.286, pp.22711-22715, 2011. ,
Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme, J. Endocrinol, vol.177, pp.399-405, 2003. ,
Stem cell antigen-1 localizes to lipid microdomains and associates with insulin degrading enzyme in skeletal myoblasts, J. Cell. Physiol, vol.217, pp.250-260, 2008. ,
Deletion of the fission yeast homologue of human insulinase reveals a TORC1-dependent pathway mediating resistance to proteotoxic stress, PLoS ONE, vol.8, p.67705, 2013. ,
Proteolytically inactive insulin-degrading enzyme inhibits amyloid formation yielding non-neurotoxic Ab peptide aggregates, PLoS ONE, vol.8, p.59113, 2013. ,
Effect of insulinase-inhibitor on hypoglycemic action of insulin, Science, vol.122, pp.559-560, 1955. ,
Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat, Nat. Genet, vol.12, pp.31-37, 1996. ,
Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats, Hum. Mol. Genet, vol.9, pp.2149-2158, 2000. ,
Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein, Am. J. Pathol, vol.164, pp.1425-1434, 2004. ,
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo, Proc. Natl Acad. Sci. USA, vol.100, pp.4162-4167, 2003. ,
Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance, PLoS ONE, vol.6, p.20818, 2012. ,
Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin, PLoS ONE, vol.5, p.10504, 2010. ,
Optimization of peptide hydroxamate inhibitors of insulin-degrading enzyme reveals marked substrate-selectivity, J. Med. Chem, vol.56, pp.2246-2255, 2013. ,
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones, Nature, vol.511, pp.94-98, 2014. ,
Kinetic target-guided synthesis, Chem. Soc. Rev, vol.39, pp.1316-1324, 2010. ,
Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks, Angew. Chem. Int. Ed. Engl, vol.41, pp.1053-1057, 2002. ,
In situ click chemistry: enzyme inhibitors made to their own specifications, J. Am. Chem. Soc, vol.126, pp.12809-12818, 2004. ,
In situ click chemistry: enzyme-generated inhibitors of carbonic anhydrase II, Angew. Chem. Int. Ed. Engl, vol.44, p.116, 2005. ,
Inhibitors of HIV-1 protease by using in situ click chemistry, Angew. Chem. Int. Ed. Engl, vol.45, pp.1435-1439, 2006. ,
Chitinase inhibitors: extraction of the active framework from natural argifin and use of in situ click chemistry, J. Antibiot, vol.62, p.277, 2009. ,
Exploring drug target flexibility using in situ click chemistry: application to a mycobacterial transcriptional regulator, ACS Chem. Biol, vol.5, pp.1007-1013, 2010. ,
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-b hydrolysis, Eur. J. Med. Chem, vol.79, pp.184-193, 2014. ,
Absolute potassium cation affinities (PCAs) in the gas phase, Chemistry, vol.9, p.3383, 2003. ,
4-oxadiazoles: a theoretical study of electric dipole moments, Theor. Chim. Acta, vol.2, pp.435-446, 1968. ,
Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme, Proc. Natl Acad. Sci. USA, vol.110, pp.13827-13832, 2013. ,
Hydroxamates: relationships between structure and plasma stability, J. Med. Chem, vol.52, pp.6790-6802, 2009. ,
Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation, J. Biol. Chem, vol.273, pp.32730-32738, 1998. ,
Insulindegrading enzyme rapidly removes the b-amyloid precursor protein intracellular domain (AICD), J. Biol. Chem, vol.277, pp.13389-13393, 2002. ,
Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme, J. Biol. Chem, vol.284, pp.14177-14188, 2009. ,
Processing of X-ray diffraction data collected in oscillation mode, Methods Enzymol, vol.276, pp.307-326, 1997. ,
The CCP4 molecular-graphics project, Acta Crystallogr. D Biol. Crystallogr, vol.58, pp.1955-1957, 2002. ,
Coot: model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr, vol.60, pp.2126-2132, 2004. ,
PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D, vol.66, pp.213-221, 2010. ,
Determination of the regularization parameter in indirecttransform methods using perceptual criteria, J. Appl. Cryst, vol.25, pp.495-503, 1992. ,
CRYSOL-a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates, J. Appl. Cryst, vol.28, pp.768-773, 1995. ,
performed the pharmacokinetic study in mice, NH, EW performed ITT, OGTT IPGTT in C57Bl6 mice, EE performed the pharmacodynamic study in OGTT in C57BL/6 and NOD both WT and Ide À / À , and the GSIS experiments ,